SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-002359
Filing Date
2024-01-29
Accepted
2024-01-29 06:21:10
Documents
21
Period of Report
2024-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20240128_8k.htm   iXBRL 8-K 46097
2 EXHIBIT 4.3 ex_620293.htm EX-4.3 106161
3 EXHIBIT 4.4 ex_620294.htm EX-4.4 107989
4 EXHIBIT 10.1 ex_620295.htm EX-10.1 98188
5 EXHIBIT 10.2 ex_620296.htm EX-10.2 204834
6 EXHIBIT 99.1 ex_620305.htm EX-99.1 15925
11 ex_620305img001.jpg GRAPHIC 5254
  Complete submission text file 0001437749-24-002359.txt   859651

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240128.xsd EX-101.SCH 3409
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240128_def.xml EX-101.DEF 11424
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240128_lab.xml EX-101.LAB 15310
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240128_pre.xml EX-101.PRE 11584
22 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240128_8k_htm.xml XML 2828
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 24569998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)